THE BASIC PRINCIPLES OF ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

In Segment A, contributors will get distinct doses and schedules of oral ABBV-744 pill to detect Risk-free dosing regimen. Additional contributors might be enrolled with the recognized monotherapy dosign program. In Segment B, members will acquire oral ruxolitinib and ABBV-744 might be provided as "insert-on" therapy. In Phase C, contributors will